Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker

Figure 1

The expression levels of B4GALNT1 across cancers. (a) Data of GTEx database showed the expression levels of B4GALNT1 in normal tissues. (b) Data of CCLE database showed the expression levels of B4GALNT1 across different cancer lines. (c) Data of TCGA and GTEx database showed the expression of B4GALNT1 in diverse tumors and normal tissues. (d) Data of TCGA database using TIMER2 approach showed the expression levels of B4GALNT1 across multiple tumors and normal tissues. (e) Data of GTEx comparing tumor tissues and normal tissues in LAML LGG and UCS. (f) Data of GEPIA2 showed the expression levels of B4GALNT1 in different pathological stages of tumors.

(a)

(b)

(c)

(d)

(e)

(f)